1. Health Strategies Group
Key Finding #1
9/19/2018
Health Strategies Group
Author/Artist
Pricing and Ability to Reduce Exacerbations are Most Important Attributes in Stakeholder Access Decisions
Health plans acknowledge that lower net pricing is a primary driver of access decisions in COPD, and predictive analysis confirms this.
We'll say to the manufacturers, we think you're more similar than different. So from a financial perspective, now it's a horse race based on best pricing or other unique contract terms. – National Plan Pharmacy
While net pricing is important, plans also consider other measures that impact finances when making access decisions, such as the total cost of patient care and long-term data on ER/hospitalization reductions.
Medical groups are most driven by efficacy scores, reduced hospitalization/ER data, and quality-of- life data in preferred product selection since they are driven by patient outcomes and well-being.
COPD patients tend to be older and more fragile than my asthma patients … they can be trickier in terms of preventing the exacerbations and hospitalizations. – Medical Group Primary Care
To request slides